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Abstract:
Background:
Orofacial clefts are one of the most common birth defects with multifactorial and only partly understood morphopathogenesis.
Objective:
The aim of this study was to evaluate the presence of TGF-β1, HGF, IGF-1 and IGF-1R in cleft affected mucosa of the lip.
Methods:
Lip mucosa tissue samples were obtained during surgical cleft correction from seven 2 to 6 months old children. Prepared tissue
sections  were  stained  by  immunohistochemistry  for  TGF-β1,  HGF,  IGF-1  and  IGF-1R.  The  intensity  of  staining  was  graded
semiquantitatively.
Results:
We found numerous TGF-β1 and HGF-containing epithelial and connective tissue cells, moderate number of IGF-1 immunoreactive
cells and even less pronounced presence of IGF-1R-positive cells.
Conclusion:
TGF-β1 and HGF are present in defective epithelia and soft tissue in cleft affected lip. Expressions of IGF-1 and IGF-1R show
significant differences, and both factors play a role in the morphopathogenesis of clefts.
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1. INTRODUCTION
Orofacial clefts - cleft lips, alveolar ridges and palates are one of the most common birth defects with multifactorial
and only partly understood morphopathogenesis. Over 500 different complex genetic disorders include cleft formation
[1].
TGF-β1 (Transforming growth factor beta 1) belongs to the TGF-β superfamily of approximately 40 cytokines and
takes  part  in  controlling  proliferation,  differentiation  and  survival  in  various  cell  types  [2].  TGF-β1  is  secreted  by
myofibroblasts,  inflammatory  cells,  endothelial  cells  and  epithelial  cells  and  takes  part  in  burn  scar  contracture
formation [3]. Similarly, TGF-β1 also modulates wound inflammation and granulation tissue formation [4]. To date, the
role  of  TGF  in  the  formation  of  clefts  has  been  evaluated  in  several  studies.  TGF-β3  is  found  to  be  decreasingly
expressed in glands and epithelium of unaffected cleft of lip, alveolus with or without  cleft  palate  compared to healthy
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tissue [5]. Simultaneously, TGF-alpha has been studied in nonsyndromic clefts and healthy control tissue samples; it
has been shown to have low protein expression in glands of cleft of the lip or palate tissue, as well as unaffected control
tissue obtained from the lip and alveolus [6].
HGF (Hepatocyte  growth  factor)  is  secreted  by  tumor  stromal  cells;  and  cancer-associated  fibroblasts  promote
growth, survival and migration of cancer cells in an HGF-dependent manner [7]. HGF is thought to be responsible for
cancer  cell  migration,  as  well  as  their  invasion  via  cytoskeletal  assembly,  reorganization  and  dynamics.  HGF
contributes  to  cytoskeleton  remodeling,  interactions  and  distribution  [8].
IGF-1 (Insulin like growth factor 1) is phylogenetically ancient neurotrophic hormone with essential role in central
nervous system development and maturation. It is especially important in cellular neuroplasticity and signals through its
glycoprotein receptor IGF-1R (Insulin like growth factor 1 receptor) [9]. IGF-1 regulates survival and differentiation of
many types of cells, including stem cells and placental cells, and stimulates prenatal and postnatal growth. In prenatal
life, the synthesis of IGF-1 itself is regulated by various paracrine and endocrine factors and is synthesized as required.
IGF-1R is a transmembrane tetramer receptor and its downregulation is associated with the inhibition of differentiation
and induction of apoptosis [10]. IGF-1 and IGF-1R also play an initial role in cancerogenesis and their activity leads to
increased mitogenesis, cell cycle progression and protection against apoptosis [11].
The aim of this study was to evaluate the presence of TGF-β1, HGF, IGF-1 and IGF-1R in cleft affected mucosa of
the lip.
2. MATERIALS AND METHODS
Lip mucosa tissue samples were obtained during surgical lip correction from seven 2 to 6 months old children (five
boys and two girls) in the Cleft Lip and Palate Centre at the Institute of Stomatology of Riga Stradins University. Six
were patients with unilateral cleft lip and palate and one patient was with bilateral cleft lip and palate.
The study was performed in accordance with the 1964 Declaration of Helsinki. All tissue samples were obtained
after  receiving  written  informed  consent  from  the  parents  of  the  patients.  The  study  was  approved  by  the  Ethical
Committee at Riga Stradins University, permit issued in 2003.
Lip mucosa tissue was fixed in Stefanini’s solution [12]. Stefanini’s solution was made of 20 g paraformaldehyde,
150 ml picric acid, 425 ml Sorensen's phosphate buffer (pH 7.2) and 425 ml distilled water, and stored in fridge. Further
tissue samples were dehydrated and embedded in paraffin. Four micrometers thick sections were prepared and further
stained routinely with hematoxylin and eosin [13].
TGF-β1  (code  orb7087,  obtained  from rabbit,  dilution  1:100,  Biorbyt  Limited,  Cambridge,  UK),  HGF (catalog
number AF-294-NA, Lot number ALP01, obtained from goat, dilution 1:300, R&D Systems, USA), IGF-1 (catalog
number MAB291, Lot number 56408, obtained from mouse, dilution 1:50, R&D Systems, USA) and IGF-1R (catalog
number AF-305-NA, Lot number VL03, obtained from goat, dilution 1:100, R&D Systems, USA) primary antibodies
were used by biotin – streptavidin immunohistochemistry (IMH) [14].
Lip mucosa tissue samples were deparaffinized and washed in alcohol and water, then washed for 10 minutes in
wash buffer (Tris-buffered saline) and placed for 5 minutes in EDTA boiling buffer in microwave; then cooled down
and washed twice for 5 minutes in wash buffer. To decrease background staining, we used normal blocking serum for
20 minutes. All tissue samples were incubated with primary antibodies for 1 hour. Further, washing for 10 minutes in
wash buffer and incubation for 30 minutes with LSAB+LINK with biotin related secondary antibodies (code K1015,
DakoCytomation, Denmark) was performed. Afterwards we performed another washing for 5 minutes in wash buffer.
Lip mucosa samples were incubated for 25 minutes with LSAB+LINK with enzyme peroxidase labeled streptavidine
(code K0690, DakoCytomation, Denmark), which was followed by 5 minutes washing in wash buffer and 10 minutes
processing with liquid DAB substrate-chromogen system (code K3468, DakoCytomation, Denmark) to obtain positive
structure staining in brown color. Samples were then rinsed in running water and counterstained with hematoxylin to
stain the nuclei blue.
All antibodies used in the study were tested for positive and negative control.
Image processing and analysis was performed using Image Pro Plus 6.0 software (Media Cybernetics, Silver Spring,
Maryland, USA).
The intensity of immunostaining was graded semiquantitatively and labeled as follows: no positive structures in the
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visual  field  were  labeled  as  0,  few positive  structures  in  the  visual  field  were  labeled  with  +,  moderate  number  of
positive structures in the visual field were labeled with ++, numerous positive structures in the visual field were labeled
with +++, abundance of positive structures in the visual field was marked with ++++ [15].
3. RESULTS
Mostly numerous (+++) TGF-β1-containing structures were detected in all lip tissue samples (Fig. 1). TGF-β1 is
found to be expressed in epitheliocytes, as well as fibroblasts and macrophages in subepithelial tissue. In one patient's
tissue  sample,  we  observed  factor  positive  salivary  glands,  while  another  tissue  sample  showed  patchy
immunoreactivity.  Occasional  endothelial  cells  of  the  capillary  walls  were  also  immunopositive  for  TGF-β1.
Fig.  (1).  Numerous  TGF-β1-positive  fibroblasts  and  macrophages  in  subepithelial  tissue  (white  arrows),  as  well  as  TGF-β1-
containing  epithelial  cells  (black  arrows).  Occasional  endothelial  cells  of  the  capillary  walls  are  immunopositive  for  TGF-β1.
Epithelium-connective tissue junction is marked with stars. TGF-β1 IMH, x250, scale bar: 4.1 μm.
HGF-positive  epitheliocytes,  macrophages,  as  well  as  fibroblasts  were  found  in  all  patients'  tissue  samples.  In
epithelia,  we  detected  mostly  numerous  (+++)  HGF-positive  cells,  meanwhile  HGF-positive  fibroblasts  and
macrophages observed in subepithelial tissue varied from few (+) to abundance (++++) in the visual field (Fig. 2).
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Fig. (2). Numerous HGF-positive epithelial cells (black arrows) in cleft affected lip mucosa. Epithelium-connective tissue junction is
marked with stars. HGF IMH, x200, scale bar: 7.25 μm.
Mostly  moderate  (++)  number  of  IGF-1-containing  epithelial  cells  and  connective  tissue  cells  (fibroblasts,
macrophages)  (Fig.  3),  as  well  as  IGF-1R-containing  epithelial  cells  were  found  in  most  of  our  lip  mucosa  tissue
samples. The expression of both factors was often with patchy distribution and the immunoreactive cells were observed
in scattered regions. Simultaneously the immunoreactivity of IGF-1R in subepithelial tissue was weak and only some of
the tissue samples contained few IGF-1R-positive fibroblasts and macrophages.
4. DISCUSSION
Orofacial  clefts  are  constituted  of  cleft  lip,  cleft  palate,  and  cleft  lip  and palate.  Clefts  are  the  largest  group of
craniofacial  malformations.  As there is  strong familial  association,  major  etiology factor  is  the genetic  component.
While cleft palate or cleft clip and palate require surgical correction due to difficulty in breastfeeding, untreated cleft lip
or cleft lip and palate leads to social discrimination [16]. Orofacial clefting is associated with delayed facial growth or
fusion. Various signaling pathways have been suggested as the culprit for the development of the facial malformations
while one detailed mechanism is not known yet [17].  In the current study, we evaluated lip mucosa tissue samples
obtained from seven children with cleft lip and palate.
TGF-β1  contributes  to  the  formation  of  collagenous  connective  tissue  and  is  expressed  by  large  amount  of
fibroblasts and chronic inflammatory cells in reactive gingival overgrowths [18]. Compared with typical wounds there
is a higher ratio of TGF-β1 in fetal wounds. Fetal wounds are known to heal rapidly and without scar formation early in
gestation [19]. Various studies using animal models have looked at the role of TGF in the formation of clefts. It has
been found that the loss of TGF-β signaling in the palatal epithelium leads to soft palate muscle cell proliferation and
differentiation  defects  [20].  We  found  numerous  TGF-β1-containing  epithelial  cells,  fibroblasts  and  macrophages.
Some of the endothelial cells in capillaries of our tissue samples were also immunopositive for TGF-β1 and in certain
conditions endothelial cells can contain growth factors. We suggest that TGF-β1 takes part in the formation of both
defective epithelia and soft tissue in cleft affected lip.
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Our  tissue  samples  showed  prominent  immunoreactivity  also  for  HGF  with  overall  numerous  HGF-positive
epithelial and subepithelial cells. HGF is associated with head and neck squamous cell carcinoma and contributes to
proliferation,  metastasis,  angiogenesis,  the  tumor  microenvironment  and  the  immune  system  [21].  Apart  from
tumorogenesis,  it  has  been shown that  HGF is  responsible  for  the  development  of  stria  vascularis  and  nonsensory
structures of the cochlea. Lack of HGF signaling in the inner ear leads to hearing loss [22].  HGF is a mitogen and
motility  factor  and  primarily  regulates  epithelial  cell  function.  HGF actively  augments  the  proliferation  of  corneal
epithelial  cells  in  normal  and  inflammatory  conditions  [23].  Thus,  HGF  also  takes  part  in  the  development  of  the
defective epithelia and soft tissue in cleft affected lip mucosa.
Fig. (3). IGF-1-immunoreactive cells (white arrows) in subepithelial tissue of cleft affected lip tissue. Epithelium-connective tissue
junction is marked with stars. IGF-1 IMH, x250, scale bar: 4.1 μm.
IGF-1 is known to take part in the postnatal facial development as it regulates vertical face growth [24]. IGF-1 also
stimulates proliferation, wound healing and differentiation processes of periodontal ligament cells under inflammatory
conditions  [25].  Furthermore,  IGF-1  and  IGF-1R  are  expressed  early  during  embryogenesis  and  have  shown
antagonizing effects. Overexpression of IGF-1 leads to anterior expansion of head neural tissue and ectopic eyes, while
IGF-1R depletion greatly reduces head structures [26]. We found moderate number of IGF-1-containing epithelial cells
TGF-β1, HGF, IGF-1 and IGF-1R in Clefts The Open Dermatology Journal, 2017, Volume 11   51
and connective tissue cells, as well as IGF-1R-containing epithelial cells. Simultaneously only few IGF-1R-positive
connective tissue cells were found in some of the studied tissue samples. Therefore, we suggest that expressions of
IGF-1 and IGF-1R show significant differences, and both factors play a role in the morphopathogenesis of clefts.
CONCLUSION
TGF-β1 and HGF are present in defective epithelia and soft tissue in cleft affected lip. Expressions of IGF-1 and
IGF-1R show significant differences, and both factors play a role in the morphopathogenesis of clefts.
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